サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1464628

バイオイメージング市場：イメージングモダリティ別、エンドユーザー別、国別、地域別-2024-2032年の産業分析、市場規模、市場シェア、予測

Bio-imaging Market, By Imaging Modality, By End user, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 303 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
バイオイメージング市場：イメージングモダリティ別、エンドユーザー別、国別、地域別-2024-2032年の産業分析、市場規模、市場シェア、予測
出版日: 2024年04月01日
発行: AnalystView Market Insights
ページ情報: 英文 303 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

バイオイメージング市場規模は2023年に62億343万米ドルとなり、2024年から2032年にかけて16.21%のCAGRで拡大

バイオイメージング市場-市場力学

細胞生物学、生化学、分子イメージング技術のコンピュータ解析の進歩が市場需要を促進

世界のバイオイメージング市場は、今後数年間で計り知れない成長の可能性を秘めており、この技術が診断の要となることで、多くのイノベーションとビジネスチャンスがもたらされます。バイオイメージング技術は、ヘルスケアと生物医学研究における有望な進歩と考えられており、費用対効果が高く、コンパクトで持ち運び可能な、ユーザーフレンドリーな機器の開発を促進すると期待されています。分子イメージング技術のための細胞生物学、生化学、コンピュータ解析の進歩が指数関数的に進み続けているため、これらの技術に対する需要は今後10年間で大幅に増加すると予想されます。世界の慢性疾患や感染症の負担増が、世界のバイオイメージング市場成長の大きな原動力となっています。平均寿命の延びやライフスタイルの変化に伴い、がん、心血管疾患、神経疾患などの非感染性疾患が蔓延しつつあります。例えば、2022年1月の米国がん協会の報告書によると、米国では新たに約19億人のがん患者が診断され、60万9360人ががん関連で死亡すると予測されています。

バイオイメージング市場-主な洞察

弊社リサーチアナリストの分析によると、世界市場は予測期間（2024-2032年）に約16.21%のCAGRで毎年成長すると予測されています。

イメージングモダリティのセグメンテーションに基づくと、磁気共鳴イメージング（MRI）が2023年に最大市場シェアを示すと予測されました。

エンドユーザーセグメンテーションに基づくと、診断センターが2023年の主要タイプでした。

地域別では、北米が2023年に主要な収益源となった。

バイオイメージング市場-セグメンテーション分析：

世界のバイオイメージング市場は、イメージングモダリティ、エンドユーザー、地域に基づいてセグメント化されます。

市場はイメージングモダリティに基づいて6つのカテゴリーに分類される：磁気共鳴イメージング（MRI）、コンピュータ断層撮影法（CT）、位置放射断層撮影法（PET）、超音波、X線、その他。2023年、磁気共鳴イメージング（MRI）は、汎用性、非侵襲性、卓越した空間分解能で有名なイメージングモダリティとして台頭し、幅広い臨床および研究エンドユーザに適しています。MRIの技術は、軟部組織、臓器、解剖学的構造を顕著なコントラスト分解能で詳細に可視化することを可能にし、多様な医療分野の画像診断に不可欠なものとなっています。さらに、機能的MRI（FMRI）や磁気共鳴分光法（MRS）のような手法を通じて機能的・分子的洞察を提供するMRIの能力は、臨床と研究の両方の領域でその有効性をさらに高めています。病院、診断センター、研究機関におけるMRIシステムの広範な統合は、バイオイメージング市場におけるMRIの覇権を強調しています。

市場はエンドユーザーによって4つのカテゴリーに分けられる：病院・診断センター、学術・研究機関、製薬・バイオテクノロジー企業、その他。バイオイメージング市場のエンドユーザーセグメントでは、病院と診断センターが2023年に支配的なセグメントとして浮上します。この優位性は、臨床診断、治療計画、疾患モニタリングにおいてバイオイメージング技術が不可欠な役割を果たしているためです。病院や診断センターは、患者が病気や傷害の特定と管理のために画像評価を受ける一次医療施設として機能しています。慢性疾患の罹患率が上昇し、高度な画像診断サービスに対する需要が急増しているため、病院や診断センターは最先端のバイイメージング機器や技術に継続的に投資しています。さらに、バイオイメージングシステムを電子カルテ（EHR）や遠隔医療プラットフォームに統合することで、ヘルスケア提供におけるアクセシビリティと有効性が高まる。その結果、病院と診断センターは、バイオイメージング市場の需要と拡大を推進する主要なエンドユーザーであり続けています。

バイオイメージング市場：地理的洞察

バイオイメージング市場は、北米、ラテンアメリカ、欧州、アジア太平洋、中東アフリカの各地域に広がっています。これらの地域は、ビジネスをもたらす国によってさらに分けられます。

バイオイメージング市場-競合情勢：

バイオイメージング市場において、企業はイメージング技術の向上、製品提供の拡大、多様な顧客ニーズへの対応を目的に、戦略的パートナーシップを頻繁に構築しています。学術機関や研究機関との提携は、革新的なイメージング技術やアプリケーションの探求と検証を促進します。ヘルスケアプロバイダーとの提携は、臨床プロセスへのイメージングシステムのシームレスな統合を促進し、診断精度と患者ケアを向上させる。さらに、製薬会社との提携により、スクリーニングや分析のためのハイスループット・イメージング・ソリューションを提供することで、創薬や医薬品開発のイニシアチブをサポートしています。

目次

第1章 バイオイメージング市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 バイオイメージングの主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 バイオイメージング産業研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 バイオイメージング市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 バイオイメージング市場情勢

  • バイオイメージング市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 バイオイメージング市場- 画像モダリティ別

  • 概要
    • 画像モダリティ別セグメントシェア分析
    • 磁気共鳴イメージング（MRI）
    • コンピュータ断層撮影（CT）
    • 位置放射断層撮影（PET）
    • 超音波
    • X線
    • その他

第8章 バイオイメージング市場- エンドユーザー別

  • 概要
    • エンドユーザー別セグメントシェア分析
    • 病院と診断センター
    • 学術調査機関
    • 製薬・バイオテクノロジー企業
    • その他

第9章 バイオイメージング市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第10章 主要ベンダー分析- バイオイメージング業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Bracco Imaging SPA
    • Bayer HealthCare Pharmaceuticals
    • Esaote SpA
    • Digirad Corporation
    • FONAR Corporation
    • GE Healthcare
    • Hologic Inc
    • Hitachi Medical Corporation
    • Lantheus Medical Imaging, Inc.
    • Covidien Pharmaceuticals
    • Mindray Medical International Limited
    • Others

第11章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Bio-imaging Market: Image Modality Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Image Modality
  • TABLE Global Bio-imaging Market, by Image Modality 2019-2032 (USD Million)
  • TABLE Bio-imaging Market: End User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Bio-imaging Market, by End User 2019-2032 (USD Million)
  • TABLE Bio-imaging Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Bio-imaging Market, by Region 2019-2032 (USD Million)
  • TABLE North America Bio-imaging Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Bio-imaging Market, by Image Modality, 2019-2032 (USD Million)
  • TABLE North America Bio-imaging Market, by End User, 2019-2032 (USD Million)
  • TABLE Europe Bio-imaging Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Bio-imaging Market, by Image Modality, 2019-2032 (USD Million)
  • TABLE Europe Bio-imaging Market, by End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Bio-imaging Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Bio-imaging Market, by Image Modality, 2019-2032 (USD Million)
  • TABLE Asia Pacific Bio-imaging Market, by End User, 2019-2032 (USD Million)
  • TABLE Latin America Bio-imaging Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Bio-imaging Market, by Image Modality, 2019-2032 (USD Million)
  • TABLE Latin America Bio-imaging Market, by End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Bio-imaging Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Bio-imaging Market, by Image Modality, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Bio-imaging Market, by End User, 2019-2032 (USD Million)
目次
Product Code: ANV2425

REPORT HIGHLIGHT

Bio-imaging Market size was valued at USD 6,203.43 Million in 2023, expanding at a CAGR of 16.21% from 2024 to 2032.

Bio-imaging is the scientific discipline focused on obtaining functional and structural images of the human body. It employs various techniques and processes to capture detailed snapshots of human tissues and anatomy at the molecular level. This technology plays a crucial role in the diagnosis, treatment, and prevention of diseases by utilizing advanced imaging methods. Medical bio-imaging technology is widely utilized in the examination and diagnosis of numerous diseases, contributing to the establishment of a comprehensive database of the physiology and anatomy of living organisms for further research purposes. Molecular bio-imaging specifically deals with the spatial and temporal arrangement of macromolecules, incorporating various imaging technologies ranging from X-ray, elastography, and radiography to MRI, endoscopy, tactile imaging, positron emission tomography, and ultrasound.

Bio-imaging Market- Market Dynamics

Advancements in cell biology, biochemistry, and computer analysis for molecular imaging technologies to propel market demand

The global bio-imaging market holds immense growth potential in the coming years, with the technology poised to become a cornerstone of diagnostic practices, leading to numerous innovations and business opportunities. Bio-imaging techniques are considered promising advancements in healthcare and biomedical research, expected to drive the development of cost-effective, compact, portable, and user-friendly devices. As advancements in cell biology, biochemistry, and computer analysis for molecular imaging technologies continue to progress exponentially, the demand for these technologies is anticipated to rise significantly over the next decade.The increasing burden of chronic and infectious diseases worldwide is a major driving force behind the growth of the global bio-imaging market. With rising life expectancy and changing lifestyle patterns, non-communicable diseases such as cancer, cardiovascular diseases, and neurological disorders are becoming more prevalent. For example, according to a report by the American Cancer Society in January 2022, it is projected that there will be approximately 1.9 billion new cancer cases diagnosed and 609,360 cancer-related deaths in the U.S.

Bio-imaging Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 16.21% over the forecast period (2024-2032)

Based on Imaging Modality segmentation, Magnetic Resonance Imaging was predicted to show maximum market share in the year 2023

Based on End user segmentation, and diagnostic centers was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Bio-imaging Market- Segmentation Analysis:

The Global Bio-imaging Market is segmented on the basis of Imaging Modality, End user, and Region.

The market is divided into six categories based on Imaging Modality: Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Position Emission Tomography (PET), Ultrasound, X-ray, Others. In 2023, Magnetic Resonance Imaging (MRI) emerges as a predominant imaging modality renowned for its versatility, non-invasiveness, and exceptional spatial resolution, rendering it suitable for a broad spectrum of clinical and research End users. The technology of MRI enables detailed visualization of soft tissues, organs, and anatomical structures with remarkable contrast resolution, establishing its indispensability in diagnostic imaging across diverse medical disciplines. Furthermore, MRI's capability to furnish functional and molecular insights through methodologies like functional MRI (fMRI) and magnetic resonance spectroscopy (MRS) further amplifies its efficacy in both clinical and research domains. The extensive integration of MRI systems in hospitals, diagnostic centers, and research institutions underscores its hegemony in the bio-imaging market.

The market is divided into four categories based on End user: Hospitals & diagnostic centers, Academic & research institutes, Pharmaceutical & biotech companies, others. In terms of the end-user segment within the bio-imaging market, hospitals and diagnostic centers emerge as the dominant segment in 2023. This predominance is attributed to the indispensable role of bio-imaging technologies in clinical diagnosis, treatment planning, and disease monitoring across a myriad of medical conditions. Hospitals and diagnostic centers function as primary healthcare facilities where patients undergo imaging assessments for the identification and management of ailments and injuries. With the escalating incidence of chronic illnesses and the burgeoning demand for advanced diagnostic imaging services, hospitals and diagnostic centers persistently invest in cutting-edge bi-imaging equipment and technologies. Furthermore, the integration of bio-imaging systems into electronic health records (EHR) and telemedicine platforms enhances their accessibility and efficacy in healthcare delivery. Consequently, hospitals and diagnostic centers remain the principal end-users propelling demand and expansion in the bio-imaging market.

Bio-imaging Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Bio-imaging Market- Competitive Landscape:

In the bio-imaging market, companies frequently establish strategic partnerships to advance their imaging technologies, broaden their product offerings, and cater to diverse customer requirements. Collaborations with academic institutions and research organizations facilitate the exploration and validation of innovative imaging techniques and applications. Partnerships with healthcare providers facilitate the seamless integration of imaging systems into clinical processes, enhancing diagnostic precision and patient care. Additionally, alliances with pharmaceutical companies support drug discovery and development initiatives by offering high-throughput imaging solutions for screening and analysis.

Recent Developments:

In January 2024, Biocare Medical, a leading provider of fully automated instrumentation, announced a collaboration with Molecular Instruments(R) (MI), the creator of HCR Imaging technology. This cooperation combines Biocare Medical's skill in automated bio-imaging systems with MI's suite of advanced HCR(TM) Products, founding a new benchmark in automated in situ hybridization (ISH) and immunohistochemistry (IHC).

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BIO-IMAGING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHT

Bracco Imaging S.P.A

Bayer HealthCare Pharmaceuticals

Esaote S.p.A

Digirad Corporation

FONAR Corporation

GE Healthcare

Hologic Inc

Hitachi Medical Corporation

Lantheus Medical Imaging, Inc.

Covidien Pharmaceuticals

Mindray Medical International Limited

Others

GLOBAL BIO-IMAGING MARKET, BY IMAGING MODALITY - MARKET ANALYSIS, 2019 - 2032

  • Magnetic Resonance Imaging (MRI)
  • Computed Tomography (CT)
  • Position Emission Tomography (PET)
  • Ultrasound
  • X-ray
  • Others

GLOBAL BIO-IMAGING MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals & diagnostic centers
  • Academic & research institutes
  • Pharmaceutical & biotech companies
  • Others

GLOBAL BIO-IMAGING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Bio-imaging Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Bio-imaging Market Snippet by Image Modality
    • 2.1.2.Bio-imaging Market Snippet by End User
    • 2.1.3.Bio-imaging Market Snippet by Country
    • 2.1.4.Bio-imaging Market Snippet by Region
  • 2.2.Competitive Insights

3.Bio-imaging Key Market Trends

  • 3.1.Bio-imaging Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Bio-imaging Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Bio-imaging Market Opportunities
  • 3.4.Bio-imaging Market Future Trends

4.Bio-imaging Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Bio-imaging Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Bio-imaging Market Landscape

  • 6.1.Bio-imaging Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Bio-imaging Market - By Image Modality

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Image Modality, 2023 & 2032 (%)
    • 7.1.2.Magnetic Resonance Imaging (MRI)
    • 7.1.3.Computed Tomography (CT)
    • 7.1.4.Position Emission Tomography (PET)
    • 7.1.5.Ultrasound
    • 7.1.6.X-ray
    • 7.1.7.Others

8.Bio-imaging Market - By End User

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 8.1.2.Hospitals & diagnostic centers
    • 8.1.3.Academic & research institutes
    • 8.1.4.Pharmaceutical & biotech companies
    • 8.1.5.Others

9.Bio-imaging Market- By Geography

  • 9.1.Introduction
    • 9.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 9.2.North America
    • 9.2.1.Overview
    • 9.2.2.Bio-imaging Key Manufacturers in North America
    • 9.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4.North America Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
    • 9.2.5.North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.2.6.U.S.
      • 9.2.6.1.Overview
      • 9.2.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3.U.S. Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.2.6.4.U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.2.7.Canada
      • 9.2.7.1.Overview
      • 9.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3.Canada Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.2.7.4.Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 9.3.Europe
    • 9.3.1.Overview
    • 9.3.2.Bio-imaging Key Manufacturers in Europe
    • 9.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4.Europe Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
    • 9.3.5.Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.3.6.Germany
      • 9.3.6.1.Overview
      • 9.3.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3.Germany Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.3.6.4.Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.3.7.Italy
      • 9.3.7.1.Overview
      • 9.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3.Italy Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.3.7.4.Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.3.8.United Kingdom
      • 9.3.8.1.Overview
      • 9.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3.United Kingdom Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.3.8.4.United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.3.9.France
      • 9.3.9.1.Overview
      • 9.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3.France Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.3.9.4.France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.3.10.Russia
      • 9.3.10.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.2.Russia Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.3.10.3.Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.3.11.Netherlands
      • 9.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.2.Netherlands Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.3.11.3.Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.3.12.Sweden
      • 9.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.2.Sweden Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.3.12.3.Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.3.13.Poland
      • 9.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.2.Poland Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.3.13.3.Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.3.14.Rest of Europe
      • 9.3.14.1.Overview
      • 9.3.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.3.Rest of the Europe Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.3.14.4.Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 9.4.Asia Pacific (APAC)
    • 9.4.1.Overview
    • 9.4.2.Bio-imaging Key Manufacturers in Asia Pacific
    • 9.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4.Asia Pacific Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
    • 9.4.5.Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.4.6.India
      • 9.4.6.1.Overview
      • 9.4.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3.India Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.4.6.4.India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.4.7.China
      • 9.4.7.1.Overview
      • 9.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3.China Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.4.7.4.China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.4.8.Japan
      • 9.4.8.1.Overview
      • 9.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3.Japan Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.4.8.4.Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.4.9.South Korea
      • 9.4.9.1.Overview
      • 9.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3.South Korea Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.4.9.4.South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.4.10.Australia
      • 9.4.10.1.Overview
      • 9.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3.Australia Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.4.10.4.Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.4.11.Thailand
      • 9.4.11.1.Overview
      • 9.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3.Thailand Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.4.11.4.Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.4.12.Indonesia
      • 9.4.12.1.Overview
      • 9.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3.Indonesia Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.4.12.4.Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.4.13.Philippines
      • 9.4.13.1.Overview
      • 9.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3.Philippines Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.4.13.4.Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.4.14.Rest of APAC
      • 9.4.14.1.Overview
      • 9.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3.Rest of APAC Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.4.14.4.Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 9.5.Latin America
    • 9.5.1.Overview
    • 9.5.2.Bio-imaging Key Manufacturers in Latin America
    • 9.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4.Latin America Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
    • 9.5.5.Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.5.6.Brazil
      • 9.5.6.1.Overview
      • 9.5.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3.Brazil Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.5.6.4.Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.5.7.Mexico
      • 9.5.7.1.Overview
      • 9.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3.Mexico Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.5.7.4.Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.5.8.Argentina
      • 9.5.8.1.Overview
      • 9.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3.Argentina Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.5.8.4.Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.5.9.Colombia
      • 9.5.9.1.Overview
      • 9.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3.Colombia Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.5.9.4.Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.5.10.Rest of LATAM
      • 9.5.10.1.Overview
      • 9.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3.Rest of LATAM Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.5.10.4.Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 9.6.Middle East and Africa
    • 9.6.1.Overview
    • 9.6.2.Bio-imaging Key Manufacturers in Middle East and Africa
    • 9.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4.Middle East and Africa Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
    • 9.6.5.Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.6.6.Saudi Arabia
      • 9.6.6.1.Overview
      • 9.6.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3.Saudi Arabia Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.6.6.4.Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.6.7.United Arab Emirates
      • 9.6.7.1.Overview
      • 9.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3.United Arab Emirates Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.6.7.4.United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.6.8.Israel
      • 9.6.8.1.Overview
      • 9.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3.Israel Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.6.8.4.Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.6.9.Turkey
      • 9.6.9.1.Overview
      • 9.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3.Turkey Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.6.9.4.Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.6.10.Algeria
      • 9.6.10.1.Overview
      • 9.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3.Algeria Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.6.10.4.Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.6.11.Egypt
      • 9.6.11.1.Overview
      • 9.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3.Egypt Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.6.11.4.Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.6.12.Rest of MEA
      • 9.6.12.1.Overview
      • 9.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3.Rest of MEA Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.6.12.4.Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

10.Key Vendor Analysis- Bio-imaging Industry

  • 10.1.Competitive Dashboard
  • 10.2.Company Profiles
    • 10.2.1.Bracco Imaging S.P.A
    • 10.2.2.Bayer HealthCare Pharmaceuticals
    • 10.2.3.Esaote S.p.A
    • 10.2.4.Digirad Corporation
    • 10.2.5.FONAR Corporation
    • 10.2.6.GE Healthcare
    • 10.2.7.Hologic Inc
    • 10.2.8.Hitachi Medical Corporation
    • 10.2.9.Lantheus Medical Imaging, Inc.
    • 10.2.10.Covidien Pharmaceuticals
    • 10.2.11.Mindray Medical International Limited
    • 10.2.12.Others

11.360 Degree Analyst View

12.Appendix

  • 12.1.Research Methodology
  • 12.2.References
  • 12.3.Abbreviations
  • 12.4.Disclaimer
  • 12.5.Contact Us